NIDAN
Invest Now
Start SIP in
NIDAN
Performance
- Low
- ₹21
- High
- ₹21
- 52 Week Low
- ₹16
- 52 Week High
- ₹39
- Open Price₹21
- Previous Close₹20
- Volume6,000
Investment Returns
- Over 1 Month + 4.86%
- Over 3 Month -4.87%
- Over 6 Month -29.31%
- Over 1 Year -41.6%
Smart Investing Starts Here Start SIP with Nidan Laboratories And Healthcare for Steady Growth!
Nidan Laboratories And Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -8.8
- PEG Ratio
- -
- Market Cap Cr
- 29
- P/B Ratio
- 0.4
- Average True Range
- 0.82
- EPS
- 0
- Dividend Yield
- 0
- MACD Signal
- 0.06
- RSI
- 55.15
- MFI
- 43.42
Nidan Laboratories And Healthcare Financials
Nidan Laboratories And Healthcare Technicals
EMA & SMA
Current Price
₹20.50
+
0.05
(0.24%)

-
- Bearish Moving Average 6
-
- Bullish Moving Average 10
- 20 Day
- ₹19.91
- 50 Day
- ₹20.55
- 100 Day
- ₹22.70
- 200 Day
- ₹26.02
Resistance and Support
20.63
- R3 21.17
- R2 21.03
- R1 20.77
- S1 20.37
- S2 20.23
- S3 19.97
Nidan Laboratories And Healthcare Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-14 | Quarterly Results | |
2024-05-23 | Audited Results | |
2023-05-26 | Audited Results | |
2022-11-11 | Quarterly Results |
Nidan Laboratories And Healthcare F&O
About Nidan Laboratories And Healthcare
- NSE Symbol
- NIDAN
- BSE Symbol
- ISIN
- INE0J6L01013
Similar Stocks to Nidan Laboratories And Healthcare
Nidan Laboratories And Healthcare FAQs
Nidan Laboratories And Healthcare share price is ₹20 As on 19 May, 2025 | 08:21
The Market Cap of Nidan Laboratories And Healthcare is ₹28.5 Cr As on 19 May, 2025 | 08:21
The P/E ratio of Nidan Laboratories And Healthcare is -8.8 As on 19 May, 2025 | 08:21
The PB ratio of Nidan Laboratories And Healthcare is 0.4 As on 19 May, 2025 | 08:21
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.